Influence Of Chromium-enriched Yeast On Blood Glucose And Insulin Variables, Blood Lipids, And Markers Of Oxidative Stress In Subjects With Type 2 Diabetes Mellitus
Notes for this study:
|Number of Subjects
In obese type II diabetic (on medication) subjects given supplemental chromium via yeast (400 micrograms daily) for 12 weeks was associated with a decrease in blood glucose relative to placebo but all other measured biomarkers were unchanged, although a reduction in insulin and weight in both groups tended to decrease further with chromium.
Lipid peroxidation (MDA) was unaffected and the antioxidant enzymes were mostly unaffected, although a decrease in glutathoine and glutathione peroxidase seen at the end of the trial in placebo was mitigated with chromium.